- Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response. Shulman, N.S., Zolopa, A.R., Passaro, D.J., Murlidharan, U., Israelski, D.M., Brosgart, C.L., Miller, M.D., Van Doren, S., Shafer, R.W., Katzenstein, D.A. J. Acquir. Immune Defic. Syndr. (2000)